Close Menu

Arizona State University

The pace of development for CRISPR-based infectious disease assays increased as the pandemic progressed, more funding became available, and collaboration accelerated. 

The consortium aims to harmonize the use of homologous recombination deficiency as a biomarker to guide certain treatment types in cancer patients.

The test will be designed to run on a portable device that can ultimately be rolled out to point-of-need settings such as doctors' offices and workplaces.

The new method uses Takara Bio's SmartChip PCR instrument, chips, and reagents to run 5,184 reactions per chip in less than 30 minutes.

The method can be used with isothermal amplification and paper-based readouts to detect infectious disease drug resistance in low-resource areas.

Gene editing could be an issue competitive sports need to address soon, four researchers from Arizona State University write at Slate.

The researchers will evaluate recent developments in human genome editing as well as responses from the public and scientific communities.

A Positive Lab

A new study finds that a positive lab environment can encourage undergraduates to continue to perform research.

The grant was awarded as part of DARPA's Epigenetic Characterization and Observation program, which aims to develop new approaches to epigenetic analysis.

Two research groups analyzed ancient DNA samples from across the Arctic to tease out how populations in Siberia and North America are related to one another.

Pages

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.

The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.

According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.

The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.